Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ginkgolide injection in ischemic stroke (safety, phase IV)
CTR20132020Phase 4Completed
- Sponsor
- Baiyu Pharmaceutical
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Ginkgolide in ischemic stroke, sponsored by Baiyu Pharmaceutical. Started Mar 2014; status: completed.
02
Drugs
Ginkgolide
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on CTR20132020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132020.